{"bundle_type":"pith_open_graph_bundle","bundle_version":"1.0","pith_number":"pith:2020:4LTZC4IIT7QIAEALYO7UB7RBHU","short_pith_number":"pith:4LTZC4II","canonical_record":{"source":{"id":"2009.07875","kind":"arxiv","version":1},"metadata":{"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"stat.ME","submitted_at":"2020-09-16T18:09:26Z","cross_cats_sorted":[],"title_canon_sha256":"c2c0f17e7861e6885a92e33646349c700986d631527d4e78f2aa37e375c1a32f","abstract_canon_sha256":"82c4408c8f76df72c7a4d433e7be5e836bb795efd751d3c29a87306747e4fe2c"},"schema_version":"1.0"},"canonical_sha256":"e2e79171089fe080100bc3bf40fe213d043bf61a0df10399eb7edf61d6bbe670","source":{"kind":"arxiv","id":"2009.07875","version":1},"source_aliases":[{"alias_kind":"arxiv","alias_value":"2009.07875","created_at":"2026-07-05T01:35:59Z"},{"alias_kind":"arxiv_version","alias_value":"2009.07875v1","created_at":"2026-07-05T01:35:59Z"},{"alias_kind":"doi","alias_value":"10.48550/arxiv.2009.07875","created_at":"2026-07-05T01:35:59Z"},{"alias_kind":"pith_short_12","alias_value":"4LTZC4IIT7QI","created_at":"2026-07-05T01:35:59Z"},{"alias_kind":"pith_short_16","alias_value":"4LTZC4IIT7QIAEAL","created_at":"2026-07-05T01:35:59Z"},{"alias_kind":"pith_short_8","alias_value":"4LTZC4II","created_at":"2026-07-05T01:35:59Z"}],"events":[{"event_type":"record_created","subject_pith_number":"pith:2020:4LTZC4IIT7QIAEALYO7UB7RBHU","target":"record","payload":{"canonical_record":{"source":{"id":"2009.07875","kind":"arxiv","version":1},"metadata":{"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"stat.ME","submitted_at":"2020-09-16T18:09:26Z","cross_cats_sorted":[],"title_canon_sha256":"c2c0f17e7861e6885a92e33646349c700986d631527d4e78f2aa37e375c1a32f","abstract_canon_sha256":"82c4408c8f76df72c7a4d433e7be5e836bb795efd751d3c29a87306747e4fe2c"},"schema_version":"1.0"},"canonical_sha256":"e2e79171089fe080100bc3bf40fe213d043bf61a0df10399eb7edf61d6bbe670","receipt":{"kind":"pith_receipt","key_id":"pith-v1-2026-05","algorithm":"ed25519","signed_at":"2026-07-05T01:35:59.137087Z","signature_b64":"dkX6wd+mDFJyQJJef1mz9ett71ocf+iEVhNtFems/ikVRw1Hjg13O/ArjWCPUtAsXcWID/SYwPteF6cixhLQDw==","signed_message":"canonical_sha256_bytes","builder_version":"pith-number-builder-2026-05-17-v1","receipt_version":"0.3","canonical_sha256":"e2e79171089fe080100bc3bf40fe213d043bf61a0df10399eb7edf61d6bbe670","last_reissued_at":"2026-07-05T01:35:59.136668Z","signature_status":"signed_v1","first_computed_at":"2026-07-05T01:35:59.136668Z","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"source_kind":"arxiv","source_id":"2009.07875","source_version":1,"attestation_state":"computed"},"signer":{"signer_id":"pith.science","signer_type":"pith_registry","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"created_at":"2026-07-05T01:35:59Z","supersedes":[],"prev_event":null,"signature":{"signature_status":"signed_v1","algorithm":"ed25519","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signature_b64":"M0bra20cBRpvNeznGTK1efXkpEE8LZyHxGBlFTZphY4ZUDZbLZGhxGw18tojbGCDYGClIQ2XVVLZzTU7VQnIBg==","signed_message":"open_graph_event_sha256_bytes","signed_at":"2026-08-20T08:27:31.257799Z"},"content_sha256":"fa0e42de64e443a95c6df0fb1828c21c67baaae8c00e724034bd62c490c28346","schema_version":"1.0","event_id":"sha256:fa0e42de64e443a95c6df0fb1828c21c67baaae8c00e724034bd62c490c28346"},{"event_type":"graph_snapshot","subject_pith_number":"pith:2020:4LTZC4IIT7QIAEALYO7UB7RBHU","target":"graph","payload":{"graph_snapshot":{"paper":{"title":"A Survival Mediation Model with Bayesian Model Averaging","license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","headline":"","cross_cats":[],"primary_cat":"stat.ME","authors_text":"Brian P. Hobbs, H. Amy Xia, Jie Zhou, Peng Wei, Xun Jiang","submitted_at":"2020-09-16T18:09:26Z","abstract_excerpt":"Determining the extent to which a patient is benefiting from cancer therapy is challenging. Criteria for quantifying the extent of \"tumor response\" observed within a few cycles of treatment have been established for various types of solid as well as hematologic malignancies. These measures comprise the primary endpoints of phase II trials. Regulatory approvals of new cancer therapies, however, are usually contingent upon the demonstration of superior overall survival with randomized evidence acquired with a phase III trial comparing the novel therapy to an appropriate standard of care treatmen"},"claims":{"count":0,"items":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"source":{"id":"2009.07875","kind":"arxiv","version":1},"verdict":{"id":null,"model_set":{},"created_at":null,"strongest_claim":"","one_line_summary":"","pipeline_version":null,"weakest_assumption":"","pith_extraction_headline":""},"integrity":{"clean":true,"summary":{"advisory":0,"critical":0,"by_detector":{},"informational":0},"endpoint":"/pith/2009.07875/integrity.json","findings":[],"available":true,"detectors_run":[],"snapshot_sha256":"c28c3603d3b5d939e8dc4c7e95fa8dfce3d595e45f758748cecf8e644a296938"},"references":{"count":0,"sample":[],"resolved_work":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57","internal_anchors":0},"formal_canon":{"evidence_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"author_claims":{"count":0,"strong_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"builder_version":"pith-number-builder-2026-05-17-v1"},"verdict_id":null},"signer":{"signer_id":"pith.science","signer_type":"pith_registry","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"created_at":"2026-07-05T01:35:59Z","supersedes":[],"prev_event":null,"signature":{"signature_status":"signed_v1","algorithm":"ed25519","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signature_b64":"KgxnmoKst4sitYFVOjUkDonEW6OfGZzQV5j6uTk8tcqtLniY6feYNGEM2vkFEZyhIHpexweyURdwGTxbHxEjAg==","signed_message":"open_graph_event_sha256_bytes","signed_at":"2026-08-20T08:27:31.258480Z"},"content_sha256":"64925158003e6f31596ffffe789c428950aed5f944a00ac8cd0e9dda4046fffe","schema_version":"1.0","event_id":"sha256:64925158003e6f31596ffffe789c428950aed5f944a00ac8cd0e9dda4046fffe"}],"timestamp_proofs":[],"mirror_hints":[{"mirror_type":"https","name":"Pith Resolver","base_url":"https://pith.science","bundle_url":"https://pith.science/pith/4LTZC4IIT7QIAEALYO7UB7RBHU/bundle.json","state_url":"https://pith.science/pith/4LTZC4IIT7QIAEALYO7UB7RBHU/state.json","well_known_bundle_url":"https://pith.science/.well-known/pith/4LTZC4IIT7QIAEALYO7UB7RBHU/bundle.json","status":"primary"}],"public_keys":[{"key_id":"pith-v1-2026-05","algorithm":"ed25519","format":"raw","public_key_b64":"stVStoiQhXFxp4s2pdzPNoqVNBMojDU/fJ2db5S3CbM=","public_key_hex":"b2d552b68890857171a78b36a5dccf368a953413288c353f7c9d9d6f94b709b3","fingerprint_sha256_b32_first128bits":"RVFV5Z2OI2J3ZUO7ERDEBCYNKS","fingerprint_sha256_hex":"8d4b5ee74e4693bcd1df2446408b0d54","rotates_at":null,"url":"https://pith.science/pith-signing-key.json","notes":"Pith uses this Ed25519 key to sign canonical record SHA-256 digests. Verify with: ed25519_verify(public_key, message=canonical_sha256_bytes, signature=base64decode(signature_b64))."}],"merge_version":"pith-open-graph-merge-v1","built_at":"2026-08-20T08:27:31Z","links":{"resolver":"https://pith.science/pith/4LTZC4IIT7QIAEALYO7UB7RBHU","bundle":"https://pith.science/pith/4LTZC4IIT7QIAEALYO7UB7RBHU/bundle.json","state":"https://pith.science/pith/4LTZC4IIT7QIAEALYO7UB7RBHU/state.json","well_known_bundle":"https://pith.science/.well-known/pith/4LTZC4IIT7QIAEALYO7UB7RBHU/bundle.json"},"state":{"state_type":"pith_open_graph_state","state_version":"1.0","pith_number":"pith:2020:4LTZC4IIT7QIAEALYO7UB7RBHU","merge_version":"pith-open-graph-merge-v1","event_count":2,"valid_event_count":2,"invalid_event_count":0,"equivocation_count":0,"current":{"canonical_record":{"metadata":{"abstract_canon_sha256":"82c4408c8f76df72c7a4d433e7be5e836bb795efd751d3c29a87306747e4fe2c","cross_cats_sorted":[],"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"stat.ME","submitted_at":"2020-09-16T18:09:26Z","title_canon_sha256":"c2c0f17e7861e6885a92e33646349c700986d631527d4e78f2aa37e375c1a32f"},"schema_version":"1.0","source":{"id":"2009.07875","kind":"arxiv","version":1}},"source_aliases":[{"alias_kind":"arxiv","alias_value":"2009.07875","created_at":"2026-07-05T01:35:59Z"},{"alias_kind":"arxiv_version","alias_value":"2009.07875v1","created_at":"2026-07-05T01:35:59Z"},{"alias_kind":"doi","alias_value":"10.48550/arxiv.2009.07875","created_at":"2026-07-05T01:35:59Z"},{"alias_kind":"pith_short_12","alias_value":"4LTZC4IIT7QI","created_at":"2026-07-05T01:35:59Z"},{"alias_kind":"pith_short_16","alias_value":"4LTZC4IIT7QIAEAL","created_at":"2026-07-05T01:35:59Z"},{"alias_kind":"pith_short_8","alias_value":"4LTZC4II","created_at":"2026-07-05T01:35:59Z"}],"graph_snapshots":[{"event_id":"sha256:64925158003e6f31596ffffe789c428950aed5f944a00ac8cd0e9dda4046fffe","target":"graph","created_at":"2026-07-05T01:35:59Z","signer":{"key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signer_id":"pith.science","signer_type":"pith_registry"},"payload":{"graph_snapshot":{"author_claims":{"count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57","strong_count":0},"builder_version":"pith-number-builder-2026-05-17-v1","claims":{"count":0,"items":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"formal_canon":{"evidence_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"integrity":{"available":true,"clean":true,"detectors_run":[],"endpoint":"/pith/2009.07875/integrity.json","findings":[],"snapshot_sha256":"c28c3603d3b5d939e8dc4c7e95fa8dfce3d595e45f758748cecf8e644a296938","summary":{"advisory":0,"by_detector":{},"critical":0,"informational":0}},"paper":{"abstract_excerpt":"Determining the extent to which a patient is benefiting from cancer therapy is challenging. Criteria for quantifying the extent of \"tumor response\" observed within a few cycles of treatment have been established for various types of solid as well as hematologic malignancies. These measures comprise the primary endpoints of phase II trials. Regulatory approvals of new cancer therapies, however, are usually contingent upon the demonstration of superior overall survival with randomized evidence acquired with a phase III trial comparing the novel therapy to an appropriate standard of care treatmen","authors_text":"Brian P. Hobbs, H. Amy Xia, Jie Zhou, Peng Wei, Xun Jiang","cross_cats":[],"headline":"","license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"stat.ME","submitted_at":"2020-09-16T18:09:26Z","title":"A Survival Mediation Model with Bayesian Model Averaging"},"references":{"count":0,"internal_anchors":0,"resolved_work":0,"sample":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"source":{"id":"2009.07875","kind":"arxiv","version":1},"verdict":{"created_at":null,"id":null,"model_set":{},"one_line_summary":"","pipeline_version":null,"pith_extraction_headline":"","strongest_claim":"","weakest_assumption":""}},"verdict_id":null}}],"author_attestations":[],"timestamp_anchors":[],"storage_attestations":[],"citation_signatures":[],"replication_records":[],"corrections":[],"mirror_hints":[],"record_created":{"event_id":"sha256:fa0e42de64e443a95c6df0fb1828c21c67baaae8c00e724034bd62c490c28346","target":"record","created_at":"2026-07-05T01:35:59Z","signer":{"key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signer_id":"pith.science","signer_type":"pith_registry"},"payload":{"attestation_state":"computed","canonical_record":{"metadata":{"abstract_canon_sha256":"82c4408c8f76df72c7a4d433e7be5e836bb795efd751d3c29a87306747e4fe2c","cross_cats_sorted":[],"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"stat.ME","submitted_at":"2020-09-16T18:09:26Z","title_canon_sha256":"c2c0f17e7861e6885a92e33646349c700986d631527d4e78f2aa37e375c1a32f"},"schema_version":"1.0","source":{"id":"2009.07875","kind":"arxiv","version":1}},"canonical_sha256":"e2e79171089fe080100bc3bf40fe213d043bf61a0df10399eb7edf61d6bbe670","receipt":{"algorithm":"ed25519","builder_version":"pith-number-builder-2026-05-17-v1","canonical_sha256":"e2e79171089fe080100bc3bf40fe213d043bf61a0df10399eb7edf61d6bbe670","first_computed_at":"2026-07-05T01:35:59.136668Z","key_id":"pith-v1-2026-05","kind":"pith_receipt","last_reissued_at":"2026-07-05T01:35:59.136668Z","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","receipt_version":"0.3","signature_b64":"dkX6wd+mDFJyQJJef1mz9ett71ocf+iEVhNtFems/ikVRw1Hjg13O/ArjWCPUtAsXcWID/SYwPteF6cixhLQDw==","signature_status":"signed_v1","signed_at":"2026-07-05T01:35:59.137087Z","signed_message":"canonical_sha256_bytes"},"source_id":"2009.07875","source_kind":"arxiv","source_version":1}}},"equivocations":[],"invalid_events":[],"applied_event_ids":["sha256:fa0e42de64e443a95c6df0fb1828c21c67baaae8c00e724034bd62c490c28346","sha256:64925158003e6f31596ffffe789c428950aed5f944a00ac8cd0e9dda4046fffe"],"state_sha256":"f3624c6faed50d1399f810bd870e654c862b13b4c84e9067251c0aa8d1123f78"},"bundle_signature":{"signature_status":"signed_v1","algorithm":"ed25519","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signature_b64":"o4jVSjbzszHBGDtWIBOqidTuQUs3MAYlrpSHvqBecR6ZPytai/z+widU7wGabQHPKGlV0edfuFdykULvIpKyCw==","signed_message":"bundle_sha256_bytes","signed_at":"2026-08-20T08:27:31.263117Z","bundle_sha256":"76549c89db75a7a6744553a11402bd58bad43eeca92965af95a49e6176482db9"}}